The Company provides medical products and services. Its medical devices, pharmaceuticals and biotechnology assists healthcare professionals and their patients in the treatment of complex medical conditions.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
Baxter was a shining star for me until April.... I'm going to pick some up in real life now that its dropped down to 40.... Does the market realize this is a Medical Technology conglomerate? And I know they cited the new Health Care Reform as an excuse as to why their revenues will be lower, but I don't get this. If EVERYONE get's insurance now, how does that negatively impact a medical technology supplier? Further, with Health Information Technology being one of the components of the required changes to healthcare, why not jump on that? Maybe the problem is management? Any thoughts? Any reason not to start nibbling at $40 a share?
product recalls are hindering it and a majority of international revenue is hurting because of the rising us dollar and the euro is flailing.
http://finance.yahoo.com/news/Baxter-International-zacks-2488079139.html?x=0&.v=1
personally I think it may be a great opportunity to be buying now that its reached its 52 week low.